COVID-19 (Novel Coronavirus) (DynaMed)

Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Domain: 
Health
Keywords: 
experimental drugs, Treatment, CPAP, Testing, Influenza, antimalarial, chloroquine, Diagnosis, Mask, NIPPV, Therapy, antiviral drugs, remdesivir, ACE, Pneumonia, ARB, ventilator, Gloves, pregnancy, Plaquenil, convalescent plasma, HCQ, triage, BiPAP, clinical trial, Personal Protective Equipment (PPE), hydroxychloroquine, Screening, ACEI, pregnant, Review/Reference, Critical Care, Emergency Medicine, Hospital Medicine, Infectious Diseases, Internal Medicine, Pulmonary Medicine, Healthcare Professionals, EBSCO & Partners, Trusted Publisher, Health, covid2019-nCoV, Novel Coronavirus, SARS-CoV-2, WN-CoV, Wuhan Virus, Wuhan novel coronavirus, coronavirus, china virus, china flu, wuhan flu, C19, C-19, coronaviridae, betacoronavirus, covid19, covid, ncov, cov2, cov-2, cov 2, sarcov2, 2019nCoV, hubei outbreak, huanan outbreak, huanan virus, hubei virus, 2019-nCoV, 2019 pandemic, 2020 pandemic, pandemic 2019, pandemic 2020, PMIS, PMIS-C, MIS, MIS-C, hydroxychloroquine, remdesivir
Tags: 
hydroxychloroquine, remdesivir
Description: 

acute respiratory disease caused by a novel coronavirus (SARS-CoV-2) first identified in December 2019 in Wuhan, Hubei Province, China and spreading worldwide. SARS-CoV-2 is a member of beta genus coronaviruses closely related to SARS-CoV

Collection: 
COVID-19 Information
Type of Resource: 
Clinical Reference
Country: 
All (global)
Medical Specialty: 
Critical Care
Emergency Medicine
Hospital Medicine
Infectious Diseases
Internal Medicine
Pulmonary Medicine
For: 
Healthcare Professionals
Source: 
EBSCO & Partners
Trusted Publisher